该部进行的研究集中于精神病的病因和机制，以及精神病新疗法的开发。研究可能涉及具有亚临床症状的人群，高危人群以及精神分裂症和躁郁症患者。研究活动通过精神病临床学术团体（CAG）直接与南伦敦和Maudsley NHS信托机构中的地方性精神病临床服务集成。研究和临床基础设施的独特融合有助于实施该部门的学术策略。它确保研究和教学能够反映当前的临床优先事项，并确保最新的研究结果为临床实践服务。我们的最终目的是为新的临床评估和治疗方法的发展提供信息，从而使精神病患者的生活受益。为了实现这一目标，我们利用强大的现代分析
The Department of Psychosis Studies is the largest department within the IoPPN, and one of the world's largest groups conducting research on psychosis. In the last 5 years alone, the pioneering work of our staff has resulted in over 1300 scientific publications, and we currently hold approximately 25 million in research grant income. These achievements and the quality of the research carried out in our department are reflected in the Institute's achievement of a 100 percent 4 ranking for research environment in the 2014 UK Research Excellence Framework, in which our impact was judged to be 100% world-leading or internationally excellent.